Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI 10mg Research Peptide Amino USA Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine foxo4 dri peptide dosing Comparison Guide Suggested dosage: Inject 100 400mcg kg intravenously every other day